Inovio Pharmaceuticals
INO
#9625
Rank
$0.11 B
Marketcap
$1.16
Share price
-4.13%
Change (1 day)
-51.87%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -$82.31 Million USD

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -$89.87 Million USD, an increase over its 2024 earnings that were of -$0.11 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$82.31 Million-8.41%
2025 -$89.87 Million-16.07%
2024 -$0.11 Billion-20.03%
2023 -$0.14 Billion-51.56%
2022 -$0.28 Billion-8.26%
2021 -$0.31 Billion95.4%
2020 -$0.16 Billion36.62%
2019 -$0.12 Billion20.19%
2018 -$93.91 Million10.94%
2017 -$84.65 Million9.59%
2016 -$77.24 Million118.9%
2015 -$35.29 Million-10.67%
2014 -$39.5 Million83.32%
2013 -$21.55 Million
2011 -$22.23 Million15.64%
2010 -$19.23 Million37.7%
2009 -$13.96 Million2.19%
2008 -$13.66 Million-14.09%
2007 -$15.9 Million19.12%
2006 -$13.35 Million9.62%
2005 -$12.18 Million5.77%
2004 -$11.52 Million73.08%
2003 -$6.66 Million12.75%
2002 -$5.9 Million
2000 -$8.93 Million53.93%
1999 -$5.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$26.20 B-31,942.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$15.52 B-18,958.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$6.90 B-8,491.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-$1.96 Billion 2,275.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$7.69 B-9,443.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$7.88 B-9,685.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-$2.76 Million-96.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-$0.16 Billion 93.75%๐Ÿ‡บ๐Ÿ‡ธ USA